


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+9.60%
-9.82%
-1.00%
-0.49%
+1.01%
SIGI
Selective Insurance
$82.30
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
SIGI Price Performance
$77.76 (+5.84%)
$77.43 (+6.29%)
$75 (+9.73%)
$93.82 (-12.28%)
SIGI has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Investors losing confidence

Low volume

SIGI overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Has a weak balance sheet
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
SIGI Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
SIGI Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is SIGI current stock price?
What are SIGI stock strengths?
What is SIGI Risk Level?
What is SIGI market cap and volume?
What is SIGI current Stock IQ?
Should I buy SIGI stock right now?
Is SIGI a Strong Buy right now?
What does a 'Strong Buy' rating mean for SIGI?
What does a 'Strong Sell' rating mean for SIGI?
What factors influence SIGI's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+9.60%
-9.82%
-1.00%
-0.49%
+1.01%
SIGI
Selective Insurance
Current Price
$82.30
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

SIGI Price Performance
$77.76 (+5.84%)
$77.43 (+6.29%)
$75 (+9.73%)
$93.82 (-12.28%)
SIGI Analysts Opinion
SIGI Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Has a weak balance sheet
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
SIGI Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
SIGI Street Sentiment is extremely bullish and have positive views on the near-term outlook
SIGI has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Investors losing confidence

Low volume

Average key support and resistance price levels
SIGI Stock IQ
SIGI Latest Analysis
Nifty to reach 29300 by 2026 as D-St regains momentum says Nomura. ICICI Bank Infosys among top picks . Nomura forecasts Indian equities to climb 12% by end-2026 targeting the Nifty 50 at 29300. This optimistic outlook is driven by calmer geopolitics stable macros and a recovering earnings cycle. The brokerage advises selective stock picking favoring segments with muted expectations likely to improve.
Tue Dec 2, 2025
Smallcaps hit pause after a 4-year rally. Is the turnaround finally here? . Indian small-cap stocks have consolidated after a strong rally facing headwinds like stretched valuations and tighter liquidity. However easing macro pressures improving earnings and attractive valuations now present opportunities. Selective stock-picking in the small-cap space is poised to deliver strong long-term returns as the tide turns.
Tue Dec 2, 2025
Chronic Refractory Cough Market is Expected to Boom by 2034 Driven by Advancements in Treatment Options | DelveInsight. Chronic Refractory Cough Market is Expected to Boom by 2034 Driven by Advancements in Treatment Options |. DelveInsightThe chronic refractory cough market is expected to grow due to a rising diagnosed patient pool greater awareness and recognition of chronic cough as a distinct condition limitations of current off-label treatments and the anticipated launch of emerging ther
Mon Nov 24, 2025
As Penny Production Ends Copper Bonds Show Selective Strength Says Gimme Credit. NEW YORK Nov. 24 2025 /PRNewswire/ -- As the United States retires the penny Gimme Credit offers a pocket full of insights on the copper sector. According to its expert team of corporate bond analysts copper is entering a pivotal phase marked by rising long-term demand tightening supply...
Mon Nov 24, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
SIGI Stock trends
SIGI Stock performance
SIGI Stock analysis
SIGI investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.